Mia's Feed
Medical News & Research

COVID-19 Booster Vaccinations Significantly Reduce Hospitalizations in Cancer Patients

COVID-19 Booster Vaccinations Significantly Reduce Hospitalizations in Cancer Patients

Share this article

Recent studies show that COVID-19 booster shots significantly decrease hospitalizations among cancer patients, emphasizing the importance of vaccination for vulnerable populations.

2 min read

Recent research conducted by Cedars-Sinai Medical Center highlights the crucial role of COVID-19 booster shots in protecting cancer patients from severe outcomes such as hospitalization and intensive care admissions. The study, published in JAMA Oncology, analyzed data from over 161,000 cancer patients treated between 2022 and 2023 across four major U.S. healthcare systems, including Cedars-Sinai, Kaiser Permanente Northern California, Northwell Health, and the Veterans Health Administration. Findings revealed that booster vaccinations lowered the risk of hospitalization and ICU admission by approximately 29%, with one hospitalization or ICU stay prevented for every 150 to 166 boosted patients.

Cancer patients are inherently vulnerable due to immune suppression caused by both their illness and treatments, which increases their risk of severe COVID-19 complications. Experts emphasize the importance of vaccination, supported by the study’s real-world evidence showing significant benefits of booster doses. Despite these positive results, vaccination uptake among cancer patients remains suboptimal; by January 2022, about 68% had received a booster, but after new boosters targeting multiple strains became available, only 38% of patients received one.

Dr. Jane Figueiredo, the study's senior author and director of Community Health and Population Research at Cedars-Sinai, advocates for stronger encouragement for vulnerable groups to get vaccinated. The authors note that ongoing research is vital, especially as vaccine formulations evolve and new variants emerge. Additional studies are planned to assess vaccine effectiveness in populations with autoimmune diseases and organ transplant recipients.

This groundbreaking research underscores the importance of COVID-19 vaccination for high-risk groups and highlights the need for increased efforts to improve booster coverage among cancer patients, ultimately reducing severe disease outcomes and healthcare burden.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Research Shows Sound-Induced Stress Can Intensify and Extend Pain in Mice

New research from Tokyo University of Science uncovers how sound stress alone can heighten and extend pain in mice, highlighting the role of environment in pain perception and inflammation.

COVID Vaccine Access Restrictions Expand as CVS and Walgreens Adjust Offerings

CVS and Walgreens are adjusting their COVID-19 vaccination services across states due to new regulations and CDC updates, affecting vaccine availability for different age groups and regions.

Recovery Outcomes for Older Patients After Mechanical Ventilation Are Influenced by Care Needs

This study explores how care needs influence recovery outcomes in older adults after mechanical ventilation, highlighting key factors for prognosis and long-term care planning.